• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4698277)   Today's Articles (542)
Download
Rank Citation Analysis Article
Type
Number of Years Citation(s) in RCA
1
Gungabissoon U, Hacquoil K, Bains C, Irizarry M, Dukes G, Williamson R, Deane AM, Heyland DK. Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness. JPEN J Parenter Enteral Nutr 2014;39:441-8. [PMID: 24637246 DOI: 10.1177/0148607114526450] [Citation(s) in RCA: 156] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2013] [Accepted: 02/11/2014] [Indexed: 12/27/2022]
Research Support, Non-U.S. Gov't 11 156
2
Hellström PM, Tack J, Johnson LV, Hacquoil K, Barton ME, Richards DB, Alpers DH, Sanger GJ, Dukes GE. The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying. Br J Pharmacol 2016;173:1768-77. [PMID: 26924243 DOI: 10.1111/bph.13475] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2014] [Revised: 01/29/2016] [Accepted: 02/14/2016] [Indexed: 12/12/2022]  Open
Research Support, Non-U.S. Gov't 9 28
3
Hobson R, Farmer AD, Dewit OE, O'Donnell M, Hacquoil K, Robertson D, Barton ME, Dukes GE. The effects of camicinal, a novel motilin agonist, on gastro-esophageal function in healthy humans-a randomized placebo controlled trial. Neurogastroenterol Motil 2015;27:1629-37. [PMID: 26348542 DOI: 10.1111/nmo.12663] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2015] [Accepted: 07/29/2015] [Indexed: 12/22/2022]
Randomized Controlled Trial 10 21
4
Haberer LJ, Hacquoil K, Ino H, Sakamoto T, Kanemoto N, McSherry I, Hirama T. Single‐Dose Pharmacokinetics of the CCR9 Receptor Antagonist Vercirnon in Healthy US and Japanese Subjects. Clin Pharmacol Drug Dev 2013;2:387-93. [DOI: 10.1002/cpdd.41] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2012] [Accepted: 05/14/2013] [Indexed: 01/24/2023]
12 2
5
Cooper M, O'Connor‐Semmes R, Reedy BA, Hacquoil K, Gorycki P, Pannullo K, Verticelli A, Shakib S. First‐in‐Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers. Clin Pharmacol Drug Dev 2018;8:234-245. [DOI: 10.1002/cpdd.600] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2017] [Accepted: 06/07/2018] [Indexed: 12/17/2022]
7 1
6
Reedy BA, O'Connor-Semmes R, Hacquoil K, Gorycki P, Verticelli A, Molga A. First-in-Human Study for a Selective Rearranged During Transfection Tyrosine Kinase Inhibitor, GSK3352589, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers. Clin Pharmacol Drug Dev 2021;10:334-345. [PMID: 33606922 DOI: 10.1002/cpdd.911] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Accepted: 12/21/2020] [Indexed: 12/17/2022]
Randomized Controlled Trial 4 1
7
Gungabissoon U, Hacquoil K, Bains C, Dukes G, Irizarry M, Heyland D. Frequency, determinants and impact of feed intolerance amongst the critically ill. Crit Care 2012. [PMCID: PMC3363579 DOI: 10.1186/cc10768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
13
8
Gajewska-Knapik K, Kumar S, Sutton-Cole A, Palmer KR, Cahn A, Gibson RA, Kirkpatrick C, Parry S, Schneider I, Siederer S, Stylianou A, Hacquoil K, Powell M, Ellis M, McIntosh MP, Lambert P. Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open-label study. Br J Clin Pharmacol 2023;89:3681-3689. [PMID: 37485589 DOI: 10.1111/bcp.15860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Revised: 06/20/2023] [Accepted: 06/30/2023] [Indexed: 07/25/2023]  Open
Clinical Trial, Phase I 2
9
Chapman M, Fraser R, Nguyen N, Deane A, Vasist LS, Hacquoil K, Barton M, Dukes GE. Gastric emptying assessment in critically ill patients with feed intolerance; comparison of 13C octanoic acid, paracetamol and 3-O-methylglucose absorption tests. Crit Care 2012. [PMCID: PMC3363580 DOI: 10.1186/cc10769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]  Open
abstract 13
10
Wiklund SJ, Thorn K, Götte H, Hacquoil K, Saint-Hilary G, Carlton A. Going beyond probability of success: Opportunities for statisticians to influence quantitative decision-making at the portfolio level. Pharm Stat 2024;23:429-438. [PMID: 38212898 DOI: 10.1002/pst.2361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 12/18/2023] [Accepted: 12/27/2023] [Indexed: 01/13/2024]
1
Please SIGN IN to browse more articles.
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Open (4)